Literature DB >> 23783072

Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model.

Stefan Herget-Rosenthal1, Dorothea Dehnen, Andreas Kribben, Thomas Quellmann.   

Abstract

OBJECTIVE: To determine the incidence and prevalence of CKD and of progressive GFR decline, to identify modifiable risk factors of and to develop a predictive risk model for progressive GFR decline in high risk primary care patients.
METHODS: Retrospective observational study of 803 patients with or at high risk of CKD exclusively managed in primary care. Baseline data was collected in 2003, follow-up data in 2006. High risk was defined as inadequately controlled hypertension or diabetes, and GFR<60, progressive GFR decline as annual GFR decline >2.5mlmin(-1) 1.73m(-2).
RESULTS: CKD was present in 25.4% at baseline and developed in further 13.7% during follow-up, 42.5% demonstrated progressive GFR decline. Obesity, proteinuria, heart failure, inadequate hypertension and diabetes control, lacking angiotensin-converting-enzyme-inhibitors or angiotensin-receptor-blockers, radio contrast, and dual renin-angiotensin-aldosterone-system blockade were identified as modifiable, independent risk factors of progressive GFR decline. The risk model, containing 7 readily obtainable variables, showed good discriminative ability.
CONCLUSIONS: High risk primary care patients demonstrated high CKD prevalence and incidence, and rate of progressive GFR decline. Identified risk factors can be modified in primary care. Our risk model may aid primary care physicians to predict patients at high risk of progressive GFR decline.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Incidence; Prediction; Prevalence; Primary care; Progression; Risk factor

Mesh:

Year:  2013        PMID: 23783072     DOI: 10.1016/j.ypmed.2013.06.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

Review 1.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

2.  Fast GFR decline and progression to CKD among primary care patients with preserved GFR.

Authors:  Farrukh M Koraishy; Denise Hooks-Anderson; Joanne Salas; Michael Rauchman; Jeffrey F Scherrer
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

3.  Underestimated Prevalence of Chronic Heart Failure among the Elderly Residing in Care Homes in Aruba.

Authors:  E Stoutjesdijk; M Barents; R M Brouns; M Jl DeJongste; H J Besselink; J D Cheng; R Wever; F Aj Muskiet
Journal:  West Indian Med J       Date:  2014-11-04       Impact factor: 0.171

Review 4.  The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.

Authors:  H William Schnaper
Journal:  Adv Chronic Kidney Dis       Date:  2017-03       Impact factor: 3.620

5.  Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study.

Authors:  Miguel A Salinero-Fort; Francisco J San Andrés-Rebollo; Carmen de Burgos-Lunar; Paloma Gómez-Campelo; Rosa M Chico-Moraleja; Ana López de Andrés; Rodrigo Jiménez-García
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

6.  Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study.

Authors:  Azra Ramezankhani; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2017-11-28       Impact factor: 5.531

7.  Comparison and development of machine learning tools in the prediction of chronic kidney disease progression.

Authors:  Jing Xiao; Ruifeng Ding; Xiulin Xu; Haochen Guan; Xinhui Feng; Tao Sun; Sibo Zhu; Zhibin Ye
Journal:  J Transl Med       Date:  2019-04-11       Impact factor: 5.531

8.  Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction?

Authors:  Saeed Erfanpoor; Koorosh Etemad; Sara Kazempour; Farzad Hadaegh; Jalil Hasani; Fereidoun Azizi; Donna Parizadeh; Davood Khalili
Journal:  Int J Endocrinol Metab       Date:  2020-11-02

9.  A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records.

Authors:  Faye Cleary; David Prieto-Merino; Dorothea Nitsch
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.